The World Health Organization (WHO) actively responds to anthrax epidemic in the Democratic Republic of the Congo (DRC)
An alert was previously issued at the end of March 2025 following the death of dozens of buffalo and hippopotamuses in Virunga National Park in North Kivu. Samples taken on 29 March from a recently deceased hippopotamus and examined at the Goma veterinary laboratory revealed the presence of spores of the bacillus responsible for anthrax.
Anthrax is a bacterial zoonosis (disease transmissible from animals to humans) that generally affects ruminants (cows, sheep and goats). Humans can become infected through contact with a sick animal or contaminated products (such as meat, blood, wool, hides and bones). All forms of human anthrax (cutaneous, gastrointestinal and respiratory) require hospitalization and medical treatment.
To ensure a multi-sectoral response to this concerning health situation, the national departments of health, environment, fisheries and livestock, with support from partners including the World Health Organization (WHO), UNICEF, FAO and CDC Africa, have put the 'One Health' approach into practice. The close collaboration between the human, animal and environmental health services is designed to protect lives in response to health emergencies.
A delegation from these departments and organisations visited the Binza and Rutshuru health zones from 25 to 28 May 2025 to strengthen surveillance and the response to outbreaks of suspected cases of anthrax in the Binza and Lubero health zones.
'One of the high-impact measures led by the national authorities with the support of partners was the development of the national multi-sector anthrax preparedness and response plan. Through this common approach to the response, we can ensure a comprehensive response, from prevention activities to the clinical management of patients. We are confident that this health threat will soon be over,' said Dr Aline Katerekwa Ntamushigo, Medical Supervisor at the National Programme for Emergencies and Humanitarian Action (NPEHA). 'Our discussions with those involved on the ground are helping us to manage this risk effectively to protect people, animals and the environment.'
Since the announcement of the epidemic, WHO has supported the response on several levels. Dr Célestin Ndaliko, epidemiologist in charge of surveillance at the WHO Office in the DRC, was a member of the response team that went to Binza. 'There are major challenges in terms of disease detection. So, every anthrax investigation becomes an act of resilience, a glimmer of hope to prevent the spread of this devastating disease.'
As of 26 May 2025, 24 suspected human anthrax cases had been reported, alongside the deaths of 9 goats, one cow, 60 hippopotamuses and 27 buffalo reported in four health zones in the eastern province of North Kivu.
'Our support has been provided at several levels, and we are particularly keen to provide appropriate care for those affected. In most cases, the disease can be cured with antibiotics, which must be prescribed by a health professional,' explained Dr Leopold Ouedraogo, Emergency Manager in the provinces of North and South Kivu.
WHO has made more than four tonnes of medicines available to 12 health facilities, a large quantity of which has been handed over to the authorities in the Binza health zone in Rutshuru territory.
'So far, even if our Binza health zone has not yet recorded any human cases, we have what it takes to prevent and be ahead of what could happen,' said Dr Bernard Kakule, Chief Medical Officer for the Binza health zone.
WHO has played a central role in cross-border coordination between the Democratic Republic of Congo and Uganda, facilitating communication and collaboration between the two countries in response to the re-emergence of anthrax in humans and animals. Surveillance has thus been strengthened, notably by activating the 'One Health' unit in Rutshuru, to ensure early detection and rapid response in high-risk health zones by integrating the human, animal and environmental dimensions of health.
To build local capacity, the WHO has also supported the training of community relays, the development of awareness-raising materials and the conduct of public and door-to-door awareness-raising campaigns on disease prevention measures. The Organisation also donated prevention kits (chlorine, hand sanitizers), essential medicines and medical equipment for treatment, and encouraged collaboration with technical partners such as INRB to improve epidemiological surveillance.
Despite security and logistical challenges, WHO's support has enabled the foundations to be laid for a coordinated response, while highlighting the need for greater commitment to community awareness-raising, the safe management of carcasses and the vaccination of animals at risk.
Since the epidemic was announced, 24 people have been treated in health facilities in the Binza and Lubero health zones, including Pierre, who has been discharged from the hospital and resumed his life.
On the ground, our teams are still working hard to continue protecting people and their herds, working together in the face of a common threat.
Distributed by APO Group on behalf of World Health Organization (WHO) - Democratic Republic of Congo.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Al Etihad
7 hours ago
- Al Etihad
Following President's directives, UAE conducts urgent medical evacuation for patients, their families from Gaza
20 Aug 2025 22:18 ABU DHABI (WAM) In cooperation with the World Health Organisation (WHO), the United Arab Emirates has conducted a new medical evacuation flight, which included 155 patients and injured individuals, along with their family members from the Gaza Strip. The flight departed from Ramon Airport in Israel via Karam Abu Salem date, the UAE has evacuated 2,785 patients and their families to provide access to medical treatment since the onset of the latest medical evacuation flight is under the directives of President His Highness Sheikh Mohamed bin Zayed Al Nahyan, to provide medical treatment for 1,000 Palestinian children and 1,000 cancer patients throughout the nation's hospitals. These efforts demonstrate the UAE's leading and continuous commitment to alleviating the suffering of civilians in Gaza and mitigating the devastating impacts of this catastrophic humanitarian this regard, the Assistant Minister of Foreign Affairs for Development and International Organisations and Vice Chairman of the UAE Aid Agency, Sultan Mohammed Al Shamsi, emphasised the UAE's dedication to providing a rapid humanitarian response, including the urgent transport of patients and injured civilians from the Gaza Strip. These efforts demonstrate the UAE's unwavering and deep-rooted support for the Palestinians without exemption, reflecting the nation's humanitarian commitment to delivering immediate aid, supporting stability, and alleviating suffering caused by war and Shamsi underscored that the Emirati medical teams have transported critically wounded and injured patients to hospitals across Abu Dhabi, while other patients and their family members are accommodated at the Emirates Humanitarian City, where they will receive the necessary medical care, under the supervision of specialised medical Al Shamsi highlighted that the UAE provides various medical, educational, and cultural support to patients, injured, and their family members, which contribute in alleviating the dire consequences of the ongoing humanitarian crisis affecting patients, children, women, and the elderly in the onset of the crisis, the UAE has continued its leading humanitarian initiatives and extensive efforts in cooperation with UN organisations and international partners to mitigate the catastrophic impacts of the ongoing crisis and alleviate the humanitarian suffering faced by the residents of the Strip. These include medical services, provision of medication, and essential medical equipment on the UAE hospital ship anchored in Egypt's Al-Arish Port, as well as the operations of the Emirati field hospital in southern Gaza. The continuous medical evacuation flights are part of a comprehensive and urgent humanitarian response plan to mitigate the crisis and provide relief to those most in need.

Zawya
a day ago
- Zawya
Madagascar Shows Commitment to Improving Cancer Care, with Focus on Women's Health
An international review has found that Madagascar has laid strong foundations for cancer control, expanding cervical cancer services, maintaining a health workforce and ensuring collaboration between health and radiation safety authorities. The joint imPACT review by the IAEA, World Health Organization (WHO) and International Agency for Research on Cancer (IARC, highlighted the need to further develop oncology professionals and mobilize resources to increase access to cancer care across the country. Cancer claims more than 14 000 lives in Madagascar every year, with women more affected than men with 8 000 deaths. The country registers over 20,000 new cancer cases annually, according to 2022 IARC estimates. Incidence rates are expected to rise with increasing risk factors and an aging population. In June 2025, a team of 13 international experts nominated by the three organizations visited the main healthcare and specialized facilities in the country to conduct the imPACT review – which provides a baseline assessment of services to support Madagascar as the country develops its first comprehensive national cancer governance document. The experts held discussions with national and local health authorities, medical professionals and other stakeholders, and presented preliminary findings to the Minister of Health. 'The Malagasy government is committed to improving cancer care in the country,' Minister of Health Randriamanantany Zely Arivelo said. 'This imPACT assessment is very timely, as we will use its findings to finalize our country's first national cancer control plan.' Focus on Women's Cancers The most common cancer among women in Madagascar is cervical cancer, with a mortality rate of 30 per cent, followed by breast and colorectal cancers. In men, prostate, liver cancer and non-Hodgkin lymphoma are the most common cancers, driven by infectious diseases. The team assessed all elements that can impact cancer care in the country. These include factors such as governance, resources and regulatory frameworks for radiation safety, and components such as surveillance, referral networks, early diagnostic capacities, oncology workforce development opportunities, and readiness for advanced and expanded radiotherapy services. 'The strength of the imPACT review lies in its analysis of the entire cancer continuum,' said Laurent Musango, WHO Representative in Madagascar. 'The assessment reveals a solid foundation for integrating cancer control at the community level, and the potential for an overall strengthening of health systems in terms of prevention and early diagnosis.' The review found that Madagascar has been steadfast in boosting cancer services since a previous assessment in 2015. The country has expanded cervical cancer prevention, with pre-cancerous lesion screening already available and HPV vaccination set to start in October and has undertaken important efforts to modernize and distribute imaging services. The national health system also has an established and overall qualified health workforce, with six faculties of medicine available to train specialized health professionals – particularly in surgery, a critical aspect in cancer treatment. Boosting Capacity for Cancer Care The team recommended that Madagascar continue building capacity to increase and retain human resources in oncology professionals. It also urged further strengthening of radiation safety in medicine and long-term maintenance of existing equipment in nuclear medicine and radiotherapy centres. 'Radiation safety for the protection of patients, public and staff is foundational to providing comprehensive cancer diagnosis and treatment,' said Vasiliki Kamenopoulou, a radiation safety specialist at the IAEA who participated in the imPACT review. 'The Malagasy government is encouraged to reinforce the legal and regulatory framework for safety and bring it in line with the IAEA safety standards.' The review noted that Madagascar should also reinforce prevention and early detection actions for other priority cancers, including working with communities for greater breast cancer awareness and boosting pathology services with additional laboratory staff, equipment and supplies. Partnerships to Expand Services Looking forward, the imPACT review recommended strategies to support Madagascar mobilize resources for cancer control, such as the development of bankable documents to facilitate loans and public-private sector partnerships. The IAEA's Programme of Action for Cancer Therapy and Rays of Hope initiative support countries in bridging gaps in cancer care through partnerships with donors, the private sector and financial institutions. Through its technical cooperation and human health programmes, the IAEA also supports countries in strengthening the quality of nuclear and radiation medicine by providing capacity building, provision of equipment, technical advice and advisory services. Distributed by APO Group on behalf of International Atomic Energy Agency (IAEA).

Zawya
a day ago
- Zawya
From genome to action: Building Sierra Leone's next generation of genomic leaders for public health resilience beyond mpox
Sierra Leone has taken an important step in strengthening its public health system by hosting a two-week national workshop on DNA sequencing and bioinformatics from August 4 to August 15, 2025 in Freetown. The training, held under the theme 'From Genome to Action: Enhancing Mpox Surveillance through Sequencing and Bioinformatics in Sierra Leone,' was supported by the World Health Organization (WHO). It focused on building the country's capacity to track and understand diseases through genomic science, with mpox as a key focus, but also extending to other infectious diseases. The training served as a mentorship program for 16 young scientists, 15 of whom had already received foundational genomics training with WHO support. This advanced phase transitioned them to mid-level genomic experts capable of sophisticated data analysis and interpretation to inform real-time public health interventions. The sessions were practical and hands-on, covering: DNA sequencing: learning how to read and understand genetic material using Illumina platforms. Bioinformatics analysis: interpreting genetic information to see how diseases spread and change. Data stewardship: submitting results to international databases to support global knowledge. Outbreak analytic: turning genetic information into actions that help control outbreaks. The comprehensive program went beyond mpox, also covering diseases like Ebola, COVID-19, Lassa fever, HIV, and antimicrobial resistance. It also introduced broader tools that allow scientists to study different types of pathogens at once. Already, the Central Public Health Reference Laboratory (CPHRL) is applying these skills in HIV-2 research. 'This is mentorship in motion. We're growing future genomic leaders from within,' said Doris Harding, Laboratory Lead at the National Public Health Agency (NPHA). As of August 18, 2025, Sierra Leone had sequenced 10.1% (522 out of 5,154) of its confirmed mpox cases, meeting both national and continental targets of 8–10%. This progress shows how far the country has come, but also highlights the need to maintain momentum. By training participants from start to finish - sample collection to reporting, the workshop not only boosted mpox surveillance but also set the stage for sustainable genomic monitoring systems. 'This is sustainability in action – building resilient systems by empowering the laboratory pillar,' emphasized Dr. Ameh George, WHO Representative to Sierra Leone. Participants shared how the training had impacted them: 'We are deeply grateful for this investment in capacity building. The opportunity has not only enriched our professional knowledge but has also given us confidence to contribute meaningfully to research and health systems,' said Abu Bakarr Sawaneh from Connaught lab. Vidalyn Folorunso, a Medical Laboratory Scientific Officer from CPHRL added, 'Let us keep practicing, applying the knowledge gained, and making good use of it in our institutions.' Allan Campbell, CPHRL Lead&DNA Sequencing Training Lead, highlighted the lasting benefits: 'This mentorship-driven model not only meets today's needs but also builds a pipeline of future genomic experts. By empowering local scientists with the ability to lead using data and speed, Sierra Leone is strengthening its role in regional and global health security—whether in Mpox, HIV, cancer, antimicrobial resistance, or Ebola.' Walter Oguta, WHO AFRO EPI Analytics Specialist&Bioinformatics Training Lead, underscored the bigger picture: 'The workshop was a pivotal step in embedding genomic science into Sierra Leone's health system. By training a new generation of scientists, the country is now better positioned to respond to outbreaks with data-driven precision.' The August 2025 workshop stands as a milestone in Sierra Leone's public health journey. By combining mentorship, advanced training, and a focus on sustainability, it has built a new generation of scientists ready to lead the country's response to present and future health threats. This effort marks the beginning of a stronger, data-driven foundation for health security in Sierra Leone. Distributed by APO Group on behalf of World Health Organization - Sierra Leone.